BRIEF

on AMOEBA (EPA:ALMIB)

Amoéba publishes an article on its cosmetic innovation

Stock price chart of AMOEBA (EPA:ALMIB) showing fluctuations.

Amoéba, a greentech company from Chassieu, announces the publication of a scientific article in Cosmetics magazine, evaluating the impact of its Willaertia lysate on the skin. This postbiotic, derived from the hydrobiome of thermal waters, shows promising efficacy in terms of healing and reducing the signs of skin aging.

The tests, carried out mainly by independent laboratories, reveal an increase in the production of collagen and hyaluronic acid, as well as a regulation of pigmentation. The lysate helps to alleviate oxidative stress, a major cause of skin aging.

Presented at the "Skin Ageing & Challenges" conference, these results promise a breakthrough in the cosmetics sector, in line with the trend of "aging well" through natural solutions. A clinical test to confirm these results is in preparation.

R. P.

Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.

Click here to consult the press release on which this article is based

See all AMOEBA news